Atlas›Toolkit›Client card
When a client mentions it · VII-037

Hypnodelic therapy (historical)

Domain VII · Transpersonal, psychedelic & altered states · Jerome Levine, Arnold M. Ludwig · 1963 · Lexington, Kentucky

Full guide

What it is

HISTORICAL. NOT FOR USE. Hypnodelic therapy combined LSD, hypnosis and directive psychotherapy in a single session. LSD has been a Schedule I controlled substance in the US since 1970, and no regulated programme today offers this method. This entry is history only. It gives no doses, routes or…

Format

  • Format. The core was a single, intensive, individual treatment session with one therapist, embedded in an inpatient stay. There were no scheduled sessions afterwards.
  • Treatment session: induction phase. Goal: a hypnotic trance and the drug state developing together. It was held in an ordinary office, with no special lighting or music.

Who practises it, and how they are trained or regulated

  • Preparatory session. Goal: a dynamic formulation of the patient's main problems, conflicts and habitual defences, and (Lexington) training in hypnosis. It consisted of a psychiatric history interview and, at Lexington, hypnotic training. The interval before treatment varied by report: a few days in 1963 and within about ten days in 1965 and in the symposium paper. Ludwig's Outline describes no separate hypnotic…
  • Legal and regulatory status (as of the sources' dates). In the US, the 1962 Kefauver-Harris Amendments introduced safety and efficacy requirements for drug research; the dates of the later consent and IRB requirements are. Sandoz stopped supplying psychedelics for research in 1965, and nonmedical use was banned in 1970, when LSD was placed in Schedule I of the Controlled Substances Act. LSD is still Schedule I in…
  • HISTORICAL. NOT FOR USE. Hypnodelic therapy combined LSD, hypnosis and directive psychotherapy in a single session. LSD has been a Schedule I controlled substance in the US since 1970, and no regulated programme today offers this method. This entry is history only. It gives no doses, routes or administration details. Sections 4 and 5 describe what was done so that clinicians can recognise it, and then say what a…

Evidence status, as the guide reports it

  • Mendota, four arms: hypnodelic; psychedelic; LSD with a therapist who intervened only for panic or anxiety; and a no-therapy milieu control, in which patients spent equivalent time writing autobiographies of their problems and future plans. Half of each arm was also randomised to a disulfiram…

Questions to explore with your client

  • What drew you to it, and what are you hoping it will change?
  • Is there physical contact? Was it explained beforehand, and do you feel free to say no or stop at any point?
  • Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
  • Does it involve intense or unusual breathing? Have you been told about the medical conditions for which that is not advised?
  • Does it involve fasting, a special diet or 'detox'? Have you discussed this with your doctor?
  • Who runs it, and what training or registration do they hold?
  • What actually happens in a session or meeting, and how often?
  • What does it cost, and is there pressure to commit to more?
  • How do you feel afterwards, in the hours and days that follow?
  • Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

  • Shame, distrust and reluctance to take prescribed medication.
  • Marketing that cites only the Lexington pilot or two-month data.
  • The client hearing the refusal as disapproval of them; this is covered in Section 5.
  • Disclosures of facilitators who promise "guided" or "hypnotic" journeys, touch, or recovered memories.
  • Fixed beliefs adopted during the experience, especially about family or abuse, that were suggested by a guide.

When to involve someone else

  • New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
  • Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
  • A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.